![Jan Cools](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Cools
Directeur Général chez Garage Cools
Provenance du réseau au premier degré de Jan Cools
Entité | Type d'entité | Industrie | |
---|---|---|---|
Tuinwijk BV
![]() Tuinwijk BV Services to the Health IndustryHealth Services Tuinwijk BV is a Belgian housing company founded in 1928 that operates in the areas of Lokeren, Moerbeke, and Waasmunster. The private company's main focus is on providing housing solutions in these territories.
14
| Private Company | Services to the Health Industry | 14 |
Cascador Health BV
![]() Cascador Health BV Packaged SoftwareTechnology Services Cascador Health BV is a Belgian company that aims to unlock the true value of patient data for better healthcare and better health for individual patients. The company is based in Tielrode, Belgium. The company wants to bridge the gap between data providers and research/industry and become the reference for projects. It was founded in 2021 and the CEO is Philip Taillieu.
4
| Holding Company | Packaged Software | 4 |
Garage Teunkens BV
![]() Garage Teunkens BV Motor VehiclesConsumer Durables Garage TEUNKENS BV is a Belgian company that was founded in 1989 and specializes in manufacturing and assembling motor vehicles, bodies, parts, and accessories. The private company is based in Beringen, Belgium.
2
| Private Company | Motor Vehicles | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jan Cools via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
DROIA NV
![]() DROIA NV Investment ManagersFinance DROIA NV (DROIA) is an Independent Venture Capital firm founded in 2011 by Bart van Hooland. The firm is headquartered in Meise with additional office in Luxembourg. | Investment Managers | Private Equity Investor | |
Volta Management NV
![]() Volta Management NV Investment ManagersFinance Founded in 2014 by founder Frank Maene, Volta Management NV is a venture capital firm headquartered in Ghent of Belgium. | Investment Managers | Private Equity Investor | |
Itinecar NV
![]() Itinecar NV Financial ConglomeratesFinance Itinecar NV operates as a holding company with activities in the automotive sector. The company was founded on February 4, 2005 and is headquartered Ghent, Belgium. | Financial Conglomerates | Director/Board Member | |
QBIC Venture Partners BV
![]() QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium. | Investment Managers | Private Equity Investor | |
Mahzi Therapeutics, Inc.
![]() Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
QurAlis Corp.
![]() QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Summation Bio, Inc. | Director/Board Member | ||
Muna Therapeutics ApS
![]() Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
Vico Therapeutics BV
![]() Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Founder | |
Montis Biosciences BV
![]() Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | Biotechnology | Chairman | |
Volastra Therapeutics, Inc.
![]() Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Highlight Therapeutics SL
![]() Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Director/Board Member | |
PHARVARIS N.V. | Pharmaceuticals: Major | Founder | |
Arthur D. Little, Inc.
![]() Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Tusk Therapeutics Ltd.
![]() Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Premis BV | Chief Executive Officer | ||
Tusk Therapeutics SA
![]() Tusk Therapeutics SA Pharmaceuticals: MajorHealth Technology Tusk Therapeutics SA develops and manufactures therapeutic products. The private company is based in Luxembourg, Luxembourg. and has subsidiaries in Belgium. Luc Dochez has been the CEO of the Luxembourger company since 2015. | Pharmaceuticals: Major | Chief Executive Officer | |
Tusk Therapeutics NV
![]() Tusk Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Part of Tusk Therapeutics SA, Tusk Therapeutics NV operates as a research organization. The company is based in Vlaams Brabant, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
Primix Bio Ventures BV | Chief Executive Officer | ||
Katholieke Universiteit Leuven | College/University | Doctorate Degree | |
Ovizio Imaging Systems SA
![]() Ovizio Imaging Systems SA Electronic ComponentsElectronic Technology Ovizio Imaging Systems SA develops and markets imaging systems and sensors. Its microscopes include iLine F, iLine M, iLine S and QMod. The company was founded by Catherine Yourassowsky, Frank Dubois, Philip Mathuis and Serge Jooris in December 2009 and is headquartered in Brussels, Belgium. | Electronic Components | Director/Board Member | |
Vlerick Leuven Gent Management School | College/University | Masters Business Admin | |
TiGenix, Inc. | President | ||
Methexis Genomics NV | Corporate Officer/Principal | ||
TIGENIX NV | Medical Specialties | Corporate Officer/Principal | |
De Volkswoningen CVBA
![]() De Volkswoningen CVBA Services to the Health IndustryHealth Services De Volkswoningen CVBA is a Belgian company that engages in the rental and operation of social housing activities. The private company is based in Dendermonde, Belgium. The CEO of the company is Piet Pauwels. | Services to the Health Industry | Director/Board Member |
Statistiques
Internationale
Belgique | 15 |
Etats-Unis | 7 |
Pays-Bas | 6 |
Danemark | 2 |
Espagne | 2 |
Sectorielle
Health Technology | 14 |
Finance | 5 |
Health Services | 3 |
Commercial Services | 3 |
Consumer Services | 3 |
Opérationnelle
Director/Board Member | 33 |
Chief Executive Officer | 7 |
Corporate Officer/Principal | 5 |
Chairman | 3 |
Private Equity Investor | 3 |